Fresenius stock at EUR 44.99 ahead of the Xetra open: healthcare group little changed
Published on 10/19/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and trading setup
- Fresenius operates hospitals and develops medicines and infusion solutions within healthcare.
- The investor-relations calendar lists a Q3 2026 conference call for November 4, 2026.
- Fresenius stock trades pre-market at EUR 44.99 at 8:07 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.20 percent below the Xetra close of October 16, 2026.
Fresenius operates hospitals and develops medicines and infusion solutions within the healthcare market, according to its investor-relations overview. Fresenius stock trades pre-market at EUR 44.99 at 8:07 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.20 percent below the Xetra close of October 16, 2026 (EUR 45.08).
Ahead of the Xetra open
The indication is EUR 0.09 lower than that reference and is little changed on that basis. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Fresenius stock.
Business and the day ahead
The group's activities include hospitals, medicines and infusion solutions in healthcare markets, as described by Fresenius investor relations. The same overview lists November 4, 2026, for a conference call on the group's third-quarter 2026 results. Market context: Market report DAX.
